Editorial: The ever-changing scenario of first line treatment of metastatic renal cell carcinoma

被引：0

作者：

Vitale, Maria Giuseppa ^{[1
]}

Maruzzo, Marco ^{[2
]}

Sabbatini, Roberto ^{[1
]}

机构：

[1] Azienda Ospedaliero Univ Modena, Dept Oncol & Haematol, Med Oncol, Modena, Italy

[2] Ist Ricovero & Cura Carattere Sci IRCCS, Ist Oncol Veneto IOV, Dept Oncol, Med Oncol Unit 1, Padua, Italy

来源：

FRONTIERS IN ONCOLOGY | 2023年 / 13卷

关键词：

renal cancer; first line treatment; combination therapy; prognosis; nephrectomy;

D O I：

10.3389/fonc.2023.1183749

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：2

共 5 条

[1] Histological Subtype is an Independent Predictor of Outcome for Patients With Renal Cell Carcinoma
Leibovich, Bradley C.
Lohse, Christine M.
Crispen, Paul L.
Boorjian, Stephen A.
Thompson, R. Houston
Blute, Michael L.
Cheville, John C.
[J]. JOURNAL OF UROLOGY, 2010, 183 (04) : 1309 - 1315
[2] Renal cell cancer histological subtype distribution differs by race and sex
Lipworth, Loren
Morgans, Alicia K.
Edwards, Todd L.
Barocas, Daniel A.
Chang, Sam S.
Herrell, S. Duke
Penson, David F.
Resnick, Matthew J.
Smith, Joseph A.
Clark, Peter E.
[J]. BJU INTERNATIONAL, 2016, 117 (02) : 260 - 265
[3] Moch H, 2000, CANCER, V89, P604, DOI 10.1002/1097-0142(20000801)89:3<604::AID-CNCR16>3.3.CO
[4] 2-H
[5] SEER Cancer Stat Facts, KIDN REN PELV CANC